Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Johnson & Johnson

(NYSE: JNJ)
Add to Portfolio
+1.00 (+0.74%)
as of Oct 17, 2019

Last 136.17
Change +1.00 (+0.74%)
Open 135.96
Prev. Close 135.17
Today's Range
135.65
137.49
52wk Range
121.00
148.99
Volume 8,612,600
Avg Volume 7,754,735
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
JNJ +0.74% +4.58% -2.36%
DJIA +0.09% +3.92% +5.13%
S&P 500 +0.28% +3.95% +6.72%

Key Statistics

Annual EPS 6.40
Dividend Yield 2.86%
P/E Ratio 15.15
Market Capitalization, $K 350,586,750
Weighted Alpha -0.83
Standard Deviation +0.66
Profit Margin 18.32%
Beta 0.69

Growth Rates

YTD +5.52%
1-Year -2.07%
3-Year +20.04%
5-Year +32.04%
10-Year +128.91%

Opinion

Sell Hold Buy

Recent Headlines

J&J agrees to $117M settlement over pelvic mesh

AP - Thu Oct 17, 04:25PM EDT
TRENTON, N.J. (AP) — Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women's sagging pelvic organs.(full story)
JNJ: 136.17 (+1.00)

Janssen Presents New Four-Year TREMFYA®

PR Newswire via COMTEX - Thu Oct 17, 04:01PM EDT
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new long-term data from the open-label period of the Phase 3 VOYAGE 1 clinical trial. These data showed that 82 percent of patients receiving TREMFYA® ((full story)
JNJ: 136.17 (+1.00)

Jury seated in opioid case, but settlement talks go on

AP - Thu Oct 17, 01:44PM EDT
CLEVELAND (AP) — A jury was seated Thursday for the first federal trial on the opioid crisis, but the push to settle the case before opening arguments next week continued, with company officials expected to gather for furthe(full story)
CAH: 51.21 (+2.14), ABC: 89.50 (+3.45), JNJ: 136.17 (+1.00), MCK: 150.51 (+5.67)

The Latest: Jury chosen for opioid trial, but talks

AP - Thu Oct 17, 01:15PM EDT
CLEVELAND (AP) — The Latest on a federal trial over the toll of opioids (all times local):(full story)
CAH: 51.21 (+2.14), JNJ: 136.17 (+1.00), MCK: 150.51 (+5.67)

Johnson & Johnson Announces Quarterly Dividend for

PR Newswire via COMTEX - Thu Oct 17, 11:45AM EDT
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2019 of $0.95 per share on the company's common stock. The dividend is payable on December 10, 2019 t(full story)
JNJ: 136.17 (+1.00)